Definium plans DT120 NDA filing in H1 2027 as cash runway extends into 2030 (NASDAQ:DFTX)
· seekingalpha.com
Definium Q3 2026 earnings call: Phase III DT120 wins, NDA filing plans, cash runway, and launch strategy.
Earnings Call Insights Definium plans DT120 NDA filing in H1 2027 as cash runway extends into 2030 Nov 10, 2026, 4:02 AM ET Definium Therapeutics, Inc. (DFTX) S...